FRM
Fox Run Management’s United Therapeutics UTHR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-6,129
| Closed | -$1.89M | – | 1258 |
|
|
2025
Q1 | $1.89M | Buy |
6,129
+4,913
| +404% | +$1.51M | 0.29% | 35 |
|
|
2024
Q4 | $429K | Buy |
+1,216
| New | +$429K | 0.08% | 487 |
|
|
2024
Q2 | – | Sell |
-5,185
| Closed | -$1.19M | – | 1102 |
|
|
2024
Q1 | $1.19M | Sell |
5,185
-1,704
| -25% | -$391K | 0.26% | 86 |
|
|
2023
Q4 | $1.51M | Buy |
6,889
+5,668
| +464% | +$1.25M | 0.39% | 17 |
|
|
2023
Q3 | $276K | Buy |
+1,221
| New | +$276K | 0.08% | 475 |
|
|
2022
Q4 | – | Sell |
-2,377
| Closed | -$498K | – | 899 |
|
|
2022
Q3 | $498K | Buy |
+2,377
| New | +$498K | 0.19% | 180 |
|
|
2021
Q4 | – | Sell |
-2,527
| Closed | -$466K | – | 710 |
|
|
2021
Q3 | $466K | Buy |
+2,527
| New | +$466K | 0.29% | 99 |
|
|
2020
Q4 | – | Sell |
-1,994
| Closed | -$201K | – | 295 |
|
|
2020
Q3 | $201K | Buy |
+1,994
| New | +$201K | 0.5% | 126 |
|
|
2020
Q1 | – | Sell |
-3,360
| Closed | -$296K | – | 372 |
|
|
2019
Q4 | $296K | Sell |
3,360
-32
| -0.9% | -$2.82K | 0.24% | 205 |
|
|
2019
Q3 | $271K | Sell |
3,392
-1,893
| -36% | -$151K | 0.25% | 192 |
|
|
2019
Q2 | $413K | Buy |
+5,285
| New | +$413K | 0.27% | 125 |
|
|
2018
Q4 | – | Sell |
-4,406
| Closed | -$563K | – | 745 |
|
|
2018
Q3 | $563K | Buy |
4,406
+2,027
| +85% | +$259K | 0.25% | 139 |
|
|
2018
Q2 | $269K | Buy |
+2,379
| New | +$269K | 0.09% | 481 |
|
|
2017
Q3 | – | Sell |
-4,200
| Closed | -$545K | – | 880 |
|
|
2017
Q2 | $545K | Buy |
+4,200
| New | +$545K | 0.19% | 196 |
|
|
2016
Q4 | – | Sell |
-4,200
| Closed | -$496K | – | 684 |
|
|
2016
Q3 | $496K | Buy |
+4,200
| New | +$496K | 0.29% | 105 |
|
|
2016
Q2 | – | Sell |
-4,200
| Closed | -$468K | – | 676 |
|
|
2016
Q1 | $468K | Buy |
+4,200
| New | +$468K | 0.31% | 95 |
|